Lifecore Biomedical, Inc. LFCR

4.20 (0.09) (2.10%) as of 25 Sep
Market cap
$162.4M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
May '25 May '24 May '23 May '22 May '21 May '20 May '19 May '18 May '17 May '16
P/E ratio
0.00 14.75 0.00 0.00 0.00 0.00 781.10 15.62 35.77 0.00
P/S ratio
1.85 1.39 2.38 2.52 3.38 1.97 0.50 0.74 0.81 0.66
P/FCF ratio
0.00 0.00 0.00 0.00 12.14 0.00 0.00 0.00 49.47 0.00
P/Operating CF
44.74 20.42 (108.47) (510.82) 58.08 (24.89) (196.87) (745.19) 57.36 21.85
P/B ratio
179.05 15.73 0.00 3.09 1.68 1.37 1.04 1.54 1.67 1.47
EV/Sales
2.97 2.49 3.80 3.84 5.29 3.16 0.77 0.87 0.92 0.76
EV/EBITDA
0.00 39.86 308.09 6.97 25.57 40.66 15.80 15.63 15.07 0.00
EV/FCF
(30.80) (9.26) (8.46) (6.32) 19.00 (7.01) (10.16) (27.38) 55.76 (11.52)
Current Ratio
2.84 2.08 2.39 0.66 1.46 0.96 0.97 1.10 1.58 1.53
Net Debt/EBITDA
(15.59) (158.92) (20.15) 1.74 17.45 32.11 7.14 2.69 1.89 (4.56)
Debt/Equity
3.20 2.78 4.75 1.69 0.96 0.82 0.55 0.29 0.24 0.29
ROE
(701.27%) 339.11% (238.21%) (80.32%) (14.89%) (15.24%) 0.16% 10.33% 4.81% (5.38%)
ROA
(17.98%) 4.73% (37.70%) (30.02%) (6.19%) (7.20%) 0.09% 6.51% 3.02% (3.38%)
ROIC
(5.64%) (2.83%) (7.46%) (3.14%) (1.39%) (3.84%) 0.82% 2.63% 3.32% (4.89%)
Return on Tangible Assets
(24.04%) 6.28% (52.69%) (198.64%) (19.37%) (20.64%) 0.21% 14.75% 6.50% (7.72%)
Average Days of Receivables
81.26 77.07 102.58 125.68 149.91 173.77 45.54 37.51 35.66 35.52
Earnings Yield
(16.30%) 6.78% (39.04%) (34.85%) (9.60%) (12.09%) 0.13% 6.40% 2.80% (3.72%)
Free Cash Flow Yield
(5.21%) (19.38%) (18.93%) (24.16%) 8.24% (22.84%) (15.01%) (4.31%) 2.02% (10.10%)
Free Cash Flow per Share
(0.19) (0.60) (1.30) (1.74) 0.14 (1.42) (1.00) (0.50) 0.25 (0.70)
Book value per Share
1.36 1.77 1.17 2.98 6.92 7.92 9.53 9.17 8.36 7.85
Free Cash Flow
(6.62) (18.14) (38.92) (51.39) 4.16 (41.29) (28.45) (13.71) 6.92 (18.81)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 78.40 33.73 29.34 0.00
Other line items

Show all line items

Columns are period end dates